Module 2: Thursday, February 17, 2022
Nonclinical Regulatory Considerations for Human Gene Therapies: An FDA/CBER Perspective
Sandhya Sanduja, PhD
To further its mission to educate, lead, and serve, the American College of Toxicology is proud to offer a new eLearning Seminar focused on Gene Therapy. These four modules are intended to provide insight into gene therapy development for practicing toxicology professionals. The modules will feature recognized experts who will highlight the nonclinical and regulatory strategies, challenges encountered, and lessons learned from discovery to market, and beyond.
Modules will be available for purchase individually or as a discounted set of four modules. Once the live module presentations conclude, registrants will have on-demand access to the modules for 30 days from the time each archive is first accessed. Each module is 90 minutes or fewer in duration.